A new diagnostic development in MRI screening for breast cancer

A new diagnostic development in MRI screening for breast cancer - CSI in breast cancer

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON33969

Enrollment

Registered

2009-07-20

Start date

2009-03-01

Completion date

Unknown

Last updated

2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

breast cancer mamma carcinoma

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: solid breast lesion >= 1cm BIRADS classification 3 or 4 on the mammogram. Patients are >= 18 years

Exclusion criteria

Exclusion criteria: history of breast cancer breast hematoma protheses claustrophobia non-MR compatible implants disorder of kidney function

Design outcomes

Primary

Measure	Time frame
To compare the specificity of the multiple-voxel MR spectroscopy with the standard MRI and as second main aim a reduction of the number of false-positive diagnostic outcomes. Sensitivity, specificity, positive predictive value, negative predictive value and 95% CI will be calculated.	—

Secondary

Measure	Time frame
No applicable	—

Countries

Netherlands

Outcome results